Literature DB >> 18475728

Degranulation of rat omental mast cells by A(1) receptor agonists in vitro.

A M Northover1, B J Northover.   

Abstract

The haemodynamic effects of adenosine are thought to result in part from a release of mast cell amines via A3 receptor stimulation. To investigate the nature of the receptors involved in adenosine-induced mast cell degranulation in the rat isolated omentum we have used adenosine analogues with varying specificities as activators of the A(1), A(2) and A(3) receptors, and antagonists with differing specificities for A(1) and A(2) receptors. Analogues which act predominantly as A(1) (e.g. N(6)-cyclopentyladenosine) or as mixed A(1)/A(2) receptor agonists (e.g. adenosine, inosine, 5'-(Nethylcarboxamido) adenosine) caused mast cell degranulation, whereas a predominantly A3 receptor agonist (IB-MECA) was inactive. Pre-treatment of the omentum with the A(1)/A(2) receptor antagonist 8-phenyltheophylline or with the more specific A(1) receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine significantly reduced agonist-induced degranulation. Pre-treatment with disodium cromoglycate or with BN52021 also reduced degranulation of mast cells in response to N(6)-cyclopentyladenosine. In the rat isolated omental mast cell we conclude that degranulation is an indirect result of A(1) receptor stimulation. Platelet-activating factor release appears to mediate at least part of the degranulation.

Entities:  

Year:  1996        PMID: 18475728      PMCID: PMC2365807          DOI: 10.1155/S096293519600049X

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  22 in total

Review 1.  Structure and function of A1 adenosine receptors.

Authors:  J Linden
Journal:  FASEB J       Date:  1991-09       Impact factor: 5.191

2.  The effect of adenosine and its analogues on cyclic AMP changes and histamine secretion from rat peritoneal mast cells stimulated by various ligands.

Authors:  A Leoutsakos; F L Pearce
Journal:  Biochem Pharmacol       Date:  1986-04-15       Impact factor: 5.858

3.  Alternative modes of action of sodium cromoglycate.

Authors:  I M Richards; M Dixon; D M Jackson; K Vendy
Journal:  Agents Actions       Date:  1986-06

4.  Studies on the receptor mediating cyclic AMP-independent enhancement by adenosine of IgE-dependent mediator release from rat mast cells.

Authors:  M K Church; P J Hughes; C J Vardey
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

5.  Dual actions of adenosine on rat peritoneal mast cells.

Authors:  M J Lohse; K Maurer; H P Gensheimer; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

6.  [3H]Adenosine binding to rat mast cells--pharmacologic and functional characterization.

Authors:  D L Marquardt; S I Wasserman
Journal:  Agents Actions       Date:  1985-09

7.  Mast cell degranulation following adenosine A3 receptor activation in rats.

Authors:  J R Fozard; H J Pfannkuche; H J Schuurman
Journal:  Eur J Pharmacol       Date:  1996-03-18       Impact factor: 4.432

8.  Adenosine potentiates immunological histamine release from rat mast cells by a novel cyclic AMP-independent cell-surface action.

Authors:  M K Church; P J Hughes
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

9.  Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes.

Authors:  R F Bruns; J H Fergus; E W Badger; J A Bristol; L A Santay; J D Hartman; S J Hays; C C Huang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-01       Impact factor: 3.000

10.  Synergistic effects of calcium-mobilizing agents and adenosine on histamine release from rat peritoneal mast cells.

Authors:  M J Lohse; K Maurer; K N Klotz; U Schwabe
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

View more
  1 in total

1.  Mast cell amines and inosineinduced vasoconstriction in the rat hind limb.

Authors:  A M Northover; B J Northover
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.